title: Differential ligand binding affinities of human estrogen receptor-α isoforms.
abstract: Rapid non-genomic effects of 17β-estradiol are elicited by the activation of different estrogen receptor-α isoforms. Presence of surface binding sites for estrogen have been identified in cells transfected with full-length estrogen receptor-α66 (ER66) and the truncated isoforms, estrogen receptor-α46 (ER46) and estrogen receptor-α36 (ER36). However, the binding affinities of the membrane estrogen receptors (mERs) remain unknown due to the difficulty of developing of stable mER-transfected cell lines with sufficient mER density, which has largely hampered biochemical binding studies. The present study utilized cell-free expression systems to determine the binding affinities of 17β-estradiol to mERs, and the relationship among palmitoylation, membrane insertion and binding affinities. Saturation binding assays of human mERs revealed that [³H]-17β-estradiol bound ER66 and ER46 with Kd values of 68.81 and 60.72 pM, respectively, whereas ER36 displayed no specific binding within the tested concentration range. Inhibition of palmitoylation or removal of the nanolipoprotein particles, used as membrane substitute, reduced the binding affinities of ER66 and ER46 to 17β-estradiol. Moreover, ER66 and ER46 bound differentially with some estrogen receptor agonists and antagonists, and phytoestrogens. In particular, the classical estrogen receptor antagonist, ICI 182,780, had a higher affinity for ER66 than ER46. In summary, the present study defines the binding affinities for human estrogen receptor-α isoforms, and demonstrates that ER66 and ER46 show characteristics of mERs. The present data also indicates that palmitoylation and membrane insertion of mERs are important for proper receptor conformation allowing 17β-estradiol binding. The differential binding of ER66 and ER46 with certain compounds substantiates the prospect of developing mER-selective drugs.
authors: Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR.
authors: Amanda H Y
authors: AH
authors: Lin
authors: Rachel W S
authors: RW
authors: Li
authors: Eva Y W
authors: EY
authors: Ho
authors: George P H
authors: GP
authors: Leung
authors: Susan W S
authors: SW
authors: Leung
authors: Paul M
authors: PM
authors: Vanhoutte
authors: Ricky Y K
authors: RY
authors: Man
mesh_terms: D001665:Binding Sites; D002460:Cell Line; D002462:Cell Membrane; D004958:Estradiol / Q000378:metabolism; D047628:Estrogen Receptor alpha / Q000819:agonists / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D015870:Gene Expression; D006801:Humans; D008024:Ligands; D054878:Lipoylation; D048789:Phytoestrogens / Q000378:metabolism; D011485:Protein Binding; D020033:Protein Isoforms; D011499:Protein Processing, Post-Translational
chemical_list: D047628:Estrogen Receptor alpha; D008024:Ligands; D048789:Phytoestrogens; D020033:Protein Isoforms; D004958:Estradiol
references: Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4807-12
references: 12682286
references: N Engl J Med. 1991 Sep 12;325(11):756-62
references: 1870648
references: Pharmacol Res. 2011 Mar;63(3):181-9
references: 21111822
references: J Clin Endocrinol Metab. 1995 Apr;80(4):1438-43
references: 7714121
references: Nature. 1977 Jan 6;265(5589):69-72
references: 834244
references: Nucleic Acids Res. 2001 Jul 15;29(14):2905-19
references: 11452016
references: Mol Endocrinol. 2004 Dec;18(12):2854-65
references: 15231873
references: Trends Endocrinol Metab. 2001 May-Jun;12(4):152-6
references: 11295570
references: Mol Endocrinol. 1990 Oct;4(10):1465-73
references: 2178215
references: Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8517-21
references: 8078914
references: Circ Res. 2000 Oct 13;87(8):677-82
references: 11029403
references: Mol Endocrinol. 1992 Feb;6(2):157-67
references: 1569962
references: Mol Biol Cell. 2005 Jan;16(1):231-7
references: 15496458
references: Biochemistry. 2007 Feb 27;46(8):2059-69
references: 17263563
references: Crit Rev Oncol Hematol. 2002 Jul;43(1):63-76
references: 12098608
references: Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9063-8
references: 16754886
references: J Med Chem. 2004 Nov 18;47(24):5872-93
references: 15537344
references: PLoS One. 2010 Feb 02;5(2):e9013
references: 20126312
references: Mol Cell Biochem. 2006 Jul;287(1-2):61-7
references: 16699727
references: Reprod Biol Endocrinol. 2009 Sep 24;7:102
references: 19775474
references: Mol Endocrinol. 2010 Apr;24(4):709-21
references: 20197310
references: Proc Natl Acad Sci U S A. 1967 Oct;58(4):1711-8
references: 4295833
references: Mol Endocrinol. 1999 Feb;13(2):307-19
references: 9973260
references: J Steroid Biochem Mol Biol. 1994 Sep;50(5-6):313-8
references: 7918118
references: Biochem Biophys Res Commun. 2004 Apr 9;316(3):878-83
references: 15033483
references: Mol Cell Biochem. 2000 Apr;207(1-2):65-70
references: 10888228
references: Endocrinology. 2002 Mar;143(3):941-7
references: 11861516
references: Biochem Biophys Res Commun. 2005 Nov 4;336(4):1023-7
references: 16165085
references: J Proteome Res. 2008 Aug;7(8):3535-42
references: 18557639
references: Nat Rev Mol Cell Biol. 2003 Jan;4(1):46-56
references: 12511868
references: J Med Chem. 2001 Nov 22;44(24):4230-51
references: 11708925
references: Proc Natl Acad Sci U S A. 2000 May 23;97(11):5930-5
references: 10823945
references: J Biol Chem. 2003 Jan 24;278(4):2701-12
references: 12421825
references: J Pharmacol Exp Ther. 2005 Sep;314(3):1300-9
references: 15958720
references: Endocrinology. 1997 Mar;138(3):863-70
references: 9048584
references: Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):2053-8
references: 19188600
references: Arterioscler Thromb Vasc Biol. 2002 Dec 1;22(12):1952-61
references: 12482819
references: Trends Endocrinol Metab. 2009 Dec;20(10):477-82
references: 19783454
references: Trends Biotechnol. 2009 Aug;27(8):455-60
references: 19616329
references: Nat Chem Biol. 2006 Apr;2(4):207-12
references: 16520733
references: J Natl Cancer Inst. 1992 Apr 15;84(8):580-91
references: 1556769
references: Clin Chem Lab Med. 2006;44(7):883-7
references: 16776638
references: Mol Cell Endocrinol. 1991 Jul;78(3):C103-8
references: 1778298
references: Br J Pharmacol. 2005 Dec;146(8):1148-55
references: 16231002
references: FASEB J. 1995 Mar;9(5):404-10
references: 7896011
references: J Med Chem. 2000 Dec 28;43(26):4934-47
references: 11150164
references: Mol Endocrinol. 2002 Jan;16(1):100-15
references: 11773442
references: Cancer Res. 1991 Aug 1;51(15):3867-73
references: 1855205
references: Steroids. 2004 Aug;69(8-9):537-42
references: 15288766
references: EMBO J. 2000 Sep 1;19(17):4688-700
references: 10970861
references: Circulation. 2003 Jan 7;107(1):120-6
references: 12515753